Aptvision to demonstrate radiology solutions at UKIO

Aptvision will be demonstrating its suite of radiology solutions, from core radiology information systems to the referrals portal, enhanced patient engagement with our patient portal and the use of AI-powered features.

Aptvision confronts NHS waiting list challenges head-on with a mature, NHS-proven radiology information system (RIS), leveraging state-of-the-art web-based technology for secure, cost-effective, and efficient workflows benefiting patients, clinicians, and healthcare providers.

Visitors to the Aptvision stand at UKIO will have the opportunity to see live demonstrations of its radiology information system and learn firsthand of the modern and user-friendly solution which is quickly deployable and prioritises patient and user-centric experiences for imaging providers of all sizes.

With centralised referral management and AI-powered enhancements, clinicians gain access to essential tools tailored to their needs, including communication of significant alerts and results acknowledgement.

Aptvision’s patient portal significantly enhances patient experience, allowing users to tackle waiting lists by facilitating over 50 per cent self-scheduled appointments, reducing DNAs, and elevating satisfaction levels by enabling direct access to imaging, results, appointments, and procedural information with direct patient appointment messaging and e-form capability.

The company’s business intelligence tools deliver real time data, ensuring maximised resource planning and scheduling of staff across multi-site imaging centres.

Join Aptvision at the UKIO at stand A50, to witness the revolution in radiology workflow, promising superior patient experiences and staff satisfaction.

This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine.  Visit our dedicated UKIO conference page to find out more.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more